Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972104priorityCriticalpatent/ECSP972104A/en
Publication of ECSP972104ApublicationCriticalpatent/ECSP972104A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Se refiere a un método para combatir el asma con una composición que contiene una cantidad eficaz de una proteína quimérica de unión a TNF-alfa que incluye la porción soluble del receptor de TNF p55 y todos los dominios excepto el primer dominio de la región constante de la cadena pesada de la IgG1 o IgG3 humanas, y al uso de dicha proteína quimérica de unión a TNF-alfa para la preparación de un medicamento para el tratamiento del asma.Refers to a method of fighting asthma with a composition containing an effective amount of a TNF-alpha binding chimeric protein that includes the soluble portion of the TNF receptor p55 and all domains except the first domain of the constant region of the heavy chain of human IgG1 or IgG3, and the use of said TNF-alpha binding chimeric protein for the preparation of a medicament for the treatment of asthma.
ECSP9721041997-05-071997-05-07
TREATMENT OF ASTHMA WITH TNFR - IG
ECSP972104A
(en)
Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes